22.01.2014 14:50:08
|
Quest Diagnostics To Buy Solstas Lab Partners For $570 Mln - Quick Facts
(RTTNews) - Quest Diagnostics Inc. (DGX) has agreed to acquire Solstas Lab Partners Group and its units for around $570 million. Solstas is a portfolio company of Welsh, Carson, Anderson and Stowe, a private-equity firm specializing in information/business services and healthcare businesses.
Solstas is a full-service commercial laboratory company based in Greensboro, North Carolina. The company operates in 9 states across the Southeastern United States, including the Carolinas, Virginia, Tennessee, Georgia and Alabama.
The transaction, which may close in the first half of 2014, is likely to add nearly 5% in annualized revenues, about 1% of which would be from professional lab services, and be modestly accretive to adjusted earnings per share in 2014.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
Quest Diagnostics Inc. | 166,50 | -0,18% |
|